Bryce Chackerian

Has grant

Regents' Professor

University of New Mexico

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Bryce Chackerian is a Regents' Professor at the University of New Mexico, USA. His research primarily focuses on the development of virus-like particle vaccines, with notable work addressing malaria, hypercholesterolemia, and novel strategies for vaccine design. Recent publications highlight innovative approaches to vaccine synthesis and the immune response to viral infections, contributing significantly to the field of immunology.

Recent Grants

Grant: Open

Virus-like Particle based malaria vaccines targeting vulnerable epitopes in the circumsporozoite protein

Open Date: 2022-11-09

Close Date: 2027-10-31

Grant: Close

Bacteriophage virus-like particle vaccines for fentanyl and heroin overdose

Open Date: 2021-09-30

Close Date: 2024-08-31

Grant: Close

The Gonorrhea Vaccine Cooperative Research Center

Open Date: 2019-03-26

Close Date: 2025-02-28

Grant: Close

Innate-like BCR activity as a template for universal vaccination against influenza virus

Open Date: 2018-06-01

Close Date: 2023-05-31

Grant: Close

CDRH3-independent B cell stimulation to selectively expand VRC01 lineages from a fully humanized immunoglobulin repertoire

Open Date: 2017-02-17

Close Date: 2021-01-31

Articles (14)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Collaborators (2)

Koen Van Rompay

University of California, Davis

UNITED STATES

View details

Wei Cheng

University of Michigan

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Bryce Chackerian

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (14)

Virus-like particle vaccines targeting a key epitope in circumsporozoite protein provide sterilizing immunity against malaria.

Multi-phase Training in Virus-Like Particle Synthesis to Foster Science Self-efficacy in Students With Minimal Laboratory Experience.

pS396/pS404 (PHF1) tau vaccine outperforms pS199/pS202 (AT8) in rTg4510 tauopathy model

Virus-like particle-based vaccines targeting the Anopheles mosquito salivary protein TRIO

An Integrated Signaling Threshold Initiates IgG Response toward Virus-like Immunogens

PCSK9 vaccines: a promising new strategy for the treatment of hypercholesterolemia?

A bacteriophage virus-like particle vaccine against oxycodone elicits high-titer and long-lasting antibodies that sequester drug in the blood

An Approach for Antigen-Agnostic Identification of Virus-Like Particle-Displayed Epitopes that Engage Specific Antibody V Gene Regions.

A virus-like particle-based bivalent PCSK9 vaccine lowers LDL-cholesterol levels in non-human primates

A method for mapping the linear epitopes targeted by the natural antibody response to Zika virus infection using a VLP platform technology

The Immunogenicity of a VLP-based Malaria Vaccine Targeting CSP in Pregnant and Neonatal Mice.

A vaccine targeting the L9 epitope of the malaria circumsporozoite protein confers protection from blood-stage infection in a mouse challenge model

Immunogenicity and Protective Capacity of a Virus-like Particle Vaccine against <i>Chlamydia trachomatis</i> Type 3 Secretion System Tip Protein, CT584.

A VLP-based vaccine targeting ANGPTL3 lowers plasma triglycerides in mice

Collaborators (2)

Koen Van Rompay

Wei Cheng

Make your next move.